Lys29-linkage of ASK1 by Skp1−Cullin 1−Fbxo21 ubiquitin ligase complex is required for antiviral innate response
QH301-705.5
SCF complex
Science
Immunology
Herpesvirus 1, Human
MAP Kinase Kinase Kinase 5
Cell Line
antiviral response
Mice
03 medical and health sciences
Animals
Humans
Biology (General)
innate immunity
S-Phase Kinase-Associated Proteins
0303 health sciences
F-Box Proteins
Macrophages
Q
R
JNK Mitogen-Activated Protein Kinases
Herpes Simplex
Cullin Proteins
Immunity, Innate
3. Good health
Mice, Inbred C57BL
ASK1
Disease Models, Animal
HEK293 Cells
Gene Expression Regulation
Host-Pathogen Interactions
Interferon Type I
Medicine
Fbxo21
polyubiquitination
Signal Transduction
DOI:
10.7554/elife.14087
Publication Date:
2016-04-11T13:13:27Z
AUTHORS (14)
ABSTRACT
Protein ubiquitination regulated by ubiquitin ligases plays important roles in innate immunity. However, key regulators of ubiquitination during innate response and roles of new types of ubiquitination (apart from Lys48- and Lys63-linkage) in control of innate signaling have not been clearly understood. Here we report that F-box only protein Fbxo21, a functionally unknown component of SCF (Skp1–Cul1–F-box protein) complex, facilitates Lys29-linkage and activation of ASK1 (apoptosis signal-regulating kinase 1), and promotes type I interferon production upon viral infection. Fbxo21 deficiency in mice cells impairs virus-induced Lys29-linkage and activation of ASK1, attenuates c-Jun N-terminal kinase (JNK) and p38 signaling pathway, and decreases the production of proinflammatory cytokines and type I interferon, resulting in reduced antiviral innate response and enhanced virus replication. Therefore Fbxo21 is required for ASK1 activation via Lys29-linkage of ASK1 during antiviral innate response, providing mechanistic insights into non-proteolytic roles of SCF complex in innate immune response.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (57)
CITATIONS (51)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....